Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · IEX Real-Time Price · USD
2.430
0.00 (0.00%)
At close: Jul 26, 2024, 4:00 PM
2.400
-0.030 (-1.23%)
After-hours: Jul 26, 2024, 6:39 PM EDT
Esperion Therapeutics Market Cap
Esperion Therapeutics has a market cap or net worth of $460.39 million as of July 26, 2024. Its market cap has increased by 192.87% in one year.
Market Cap
460.39M
Enterprise Value
782.65M
1-Year Change
192.87%
Ranking
Category
Stock Price
$2.43
Market Cap Chart
Since June 26, 2013, Esperion Therapeutics's market cap has increased from $204.10M to $460.39M, an increase of 125.57%. That is a compound annual growth rate of 7.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 460.40M | 35.41% |
| Dec 29, 2023 | 340.00M | -25.93% |
| Dec 30, 2022 | 459.00M | 215.68% |
| Dec 31, 2021 | 145.40M | -79.94% |
| Dec 31, 2020 | 724.80M | -55.52% |
| Dec 31, 2019 | 1.63B | 32.13% |
| Dec 31, 2018 | 1.23B | -28.50% |
| Dec 29, 2017 | 1.72B | 510.80% |
| Dec 30, 2016 | 282.40M | -43.67% |
| Dec 31, 2015 | 501.30M | -39.08% |
| Dec 31, 2014 | 822.90M | 290.00% |
| Dec 31, 2013 | 211.00M | 3.38% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AxoGen | 413.01M |
| Sight Sciences | 409.99M |
| Sonida Senior Living | 408.85M |
| Alto Neuroscience | 406.49M |
| Kyverna Therapeutics | 405.71M |
| Tourmaline Bio | 396.49M |
| uniQure | 390.09M |
| Lexeo Therapeutics | 387.77M |